CRS: UpCycle Drug Repurposing Grants Competition


Cancer Research Society


The UpCycle Drug Repurposing Grants Competition is a new mean by which the Cancer Research Society aims at accelerating the discovery of treatments for cancer patients.

Eligible projects should fall into one of the following categories:

  1. Screening of an approved compound library provided by the Cancer Research Society. See their FAQ for details.
  2. Computer-assisted or in silico screening followed by pharmacological validation of FDA-approved, off-patent, repurposed compounds.
  3. In cellulo or in vivo validation of an FDA-approved, off-patent drug with demonstrated drug repurposing potential.

Research must be performed using proteins or cells of human origin unless a compelling case can be made for another organism.


This competition is open to researchers across Canada.

Maximum Project Value


Indirect Costs


Project Duration

12 to 18 months

Special Notes

*Only invited applicants can submit a complete application. Invited applicants will receive an e-mail with the PIN assigned to their project no later than April 26, 2018. If by April 30, 2018 you have not received the result of your letter of intent, please contact .


If College-level review is required, your College will communicate its earlier internal deadlines.

External Deadline

Letter of Intent: PI to submit LOI directly to CRS by e-mail to: .

* Submitting a letter of intent is mandatory. A main applicant cannot submit more than one letter of intent.

More information on this competition, forms, reports and instructions can be found on the sponsor website.

Internal Deadline

If Invited: PI to submit a copy of application along with a complete OR5 form to:

External Deadline

If Invited: PI to submit directly to CRS.  More information to follow if invited.


Information For Co-applicants

If you need to meet a deadline set by the lead institution for this opportunity, please ensure that you provide the Office of Research with at least five days in advance of the lead institution’s deadline to review the application, or your proposed component of the project. Please be in touch with the Office of Research (contact information below) ahead of the deadline if it looks like it will be difficult for you to submit all the required documentation on time (i.e. budget, proposal, OR-5 Form).

For Questions, please contact

Lucille Beaudet, Ph.D., MBA, or 514 861-9227, ext. 234
Toll-free: 1 888 766-2262, ext. 234

Office of Research

Ornella McCarron, Grants Officer
Research Services Office
519-824-4120 x52832

Alert Classifications
Funding Opportunities and Sponsor News

Health and Life Sciences